Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SECONDARY PULMONARY HYPERTENSION”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableStudy completedNCT02229994
What this trial is testing

Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases

Who this might be right for
COPD (With - Without Rehabilitation)Diffuse Interstitial Lung DiseasesPulmonary Arterial Hypertension Primary or Secondary (Post Embolic .....)+1 more
Assistance Publique - Hôpitaux de Paris 199
Not applicableUnknownNCT00348803
What this trial is testing

Gene Mutations in Secondary Pulmonary Hypertension

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
Medical University of Vienna
Not applicableStudy completedNCT05993338
What this trial is testing

Pulmonary Artery Pressure in COVID-19 Survivors

Who this might be right for
Pulmonary Hypertension Secondary
Mansoura University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT03541603
What this trial is testing

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Who this might be right for
Hypertension Pulmonary SecondaryHeart Failure, Right SidedHeart Failure With Normal Ejection Fraction
Tenax Therapeutics, Inc. 44
Large-scale testing (Phase 3)Study completedNCT00080457
What this trial is testing

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Encysive Pharmaceuticals 240
Not applicableStudy completedNCT01805843
What this trial is testing

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Medical University of Graz 16
Not applicableStudy completedNCT05131737
What this trial is testing

Exercise Endurance Time on the 2nd Day at 2500 m High Altitude

Who this might be right for
High Altitude Pulmonary Hypertension
University of Zurich 28
Not applicableUnknownNCT04035148
What this trial is testing

CPET in Evaluation of PH in COPD Patients

Who this might be right for
COPDPulmonary Hypertension Secondary
Assiut University 50
Not applicableStudy completedNCT07153783
What this trial is testing

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic Metastasis+3 more
Shengjing Hospital 10,333
Testing effectiveness (Phase 2)Ended earlyNCT01437878
What this trial is testing

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary DiseasePulmonary Hypertension
Actelion 2
Testing effectiveness (Phase 2)Study completedNCT01197469
What this trial is testing

Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?

Who this might be right for
Chronic Obstructive Pulmonary DiseasePulmonary Hypertension
University of Dundee 120
Large-scale testing (Phase 3)Study completedNCT01156636
What this trial is testing

Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure

Who this might be right for
Pulmonary HypertensionDiastolic Heart Failure
University of Milan 44
Not applicableWithdrawnNCT00155714
What this trial is testing

Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension

Who this might be right for
Primary and Secondary Pulmonary Hypertension
National Taiwan University Hospital 20
Large-scale testing (Phase 3)UnknownNCT00439543
What this trial is testing

Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Interstitial Lung Disease Study Group, Korea 15
Post-approval studies (Phase 4)Study completedNCT00862043
What this trial is testing

Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease

Who this might be right for
Pulmonary HypertensionValvular Heart Disease
Hospital General Universitario Gregorio Marañon 200
Testing effectiveness (Phase 2)Study completedNCT00414687
What this trial is testing

Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

Who this might be right for
Hypertension, Pulmonary
Bayer 63
Not applicableStudy completedNCT00011648
What this trial is testing

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia

Who this might be right for
Pulmonary HypertensionSickle Cell AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 986
Testing effectiveness (Phase 2)UnknownNCT02775539
What this trial is testing

Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure

Who this might be right for
Pulmonary HypertensionMirabegronHeart Failure+1 more
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 80
Post-approval studies (Phase 4)UnknownNCT01449253
What this trial is testing

Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia

Who this might be right for
Pulmonary Hypertension Secondary to Lung Disease and/or Hypoxia
All India Institute of Medical Sciences 60
Early research (Phase 1)UnknownNCT02403908
What this trial is testing

Catheter Denervation of Pulmonary Arteries in Treatment of IPAH & SPAH

Who this might be right for
Hypertension, Pulmonary
Clinical Hospital Centre Zagreb 60
Load More Results